查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466706

臉部注射劑市場：按類型、最終用戶分類 - 2024-2030 年全球預測

Facial Injectables Market by Type (Anti-aging Injections, Dermal Fillers), End User (Beauty Clinics, Dermatology Clinics, Dermatology Research Institutes) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年臉部注射劑市場規模為173億美元，預計2024年將達193億美元，2030年將達377.2億美元，複合年成長率為11.77%。

臉部注射劑是透過注射進行的醫療程序，旨在增強臉部美觀、使皮膚恢復活力並治療各種老化徵兆。這些是微創手術，可以暫時改善膚色、紋理和結構。對微創美容療程的需求增加、產品開發的技術進步以及可支配收入的增加使更多的人能夠負擔得起此類手術。然而，手術的高成本以及注射後併發症和副作用的風險是阻礙潛在客戶的重大問題。也就是說，個人化醫療的進步，例如根據個人臉部解剖結構和期望結果量身定做的注射劑，再加上對這些治療的安全性和有效性的持續研究，預計將為臉部護理提供未開發的潛力並創造臉部注射劑的機會。

主要市場統計
基準年[2023] 173億美元
預測年份 [2024] 193億美元
預測年份 [2030] 377.2億美元
複合年成長率（%） 11.77%

由於能夠恢復臉部體積，抗老化注射的偏好激增

抗老化老注射包括一系列旨在透過撫平皺紋和恢復臉部體積來減少老化徵兆的產品。它的作用是放鬆臉部肌肉和填充皺紋，並由醫療保健專業人員管理。 A 型肉毒桿菌毒素是一種神經調節劑，用於暫時放鬆臉部肌肉。 A 型肉毒桿菌是最受歡迎的抗老化療法之一，用於減少動態皺紋的出現，尤其是上臉上的皺紋，例如額頭紋、魚尾紋和眉間紋。聚左旋乳酸（PLLA）是一種生物分解性的合成材料，用作微粒。作為一種刺激性填充劑，PLLA 被注入皮膚深處，隨著時間的推移刺激膠原蛋白的產生，逐漸增厚皮膚並撫平皺紋。真皮填充劑是用於增加體積、改變臉部輪廓和填充皺紋的注射。常見的治療區域是嘴唇、臉頰、法令紋和木偶紋。填料由多種物質組成，其中一些是天然衍生的，一些是合成的。膠原蛋白填充劑由人類或動物膠原蛋白製成，用於取代體內隨著老齡化而減少的天然膠原蛋白。這些填充劑可以改善細紋並提供適度的提拉效果，但它們往往比其他填充劑分解得更快。透明質酸是皮膚中天然存在的物質，有助於保持水分並創造飽滿、水潤的外觀。透明質酸填充劑用於臉部注射，因為它們與身體高度相容，並且隨著時間的推移自然溶解。透明質酸填充劑通常用於唇部塑形、輪廓以及中度至重度臉部褶皺和皺紋的治療。合成填充劑由實驗室製造的物質製成，這些物質並非天然存在於皮膚中。這些填充劑，如羥基磷灰石鈣、聚乳酸和聚甲基丙烯酸甲酯珠，比使用被身體吸收的物質的填充劑提供更持久的效果，用於深層皺紋、減少體積和臉部輪廓。

最終使用者：皮膚科診所擴大採用臉部注射劑

美容診所是臉部注射劑的重要組成部分，因為它們專門從事整容手術。這些設施通常提供各種非手術美容治療，包括肉毒桿菌、真皮填充劑和其他填充劑，旨在增強臉部特徵並減少老化徵兆。皮膚科診所是臉部注射劑的重要最終使用者。這些設施由皮膚科醫生營運，並提供注射劑，作為更廣泛的皮膚護理服務的一部分。這些設施的臉部注射劑用於美容和治療目的，包括治療多汗症和某些類型的偏頭痛等疾病。皮膚病學研究機構對於推進臉部注射產品和技術至關重要。這些研究機構將優先考慮臉部注射劑，這些注射劑在皮膚病學方面具有創新和突破的潛力。我們也可以直接與製造商合作進行臨床試驗和研究，以評估長期療效和安全性。將優先考慮允許研究人員探索新人群、適應症和給藥方法的產品。醫院使用臉部注射劑的重點是重組或治療，而不是美容。臉部注射劑也可用於創傷或手術後的康復，或治療偏頭痛或出汗過多等疾病。醫院喜歡多功能、安全且經濟高效的產品，尤其是在有健康保險和預算限制的情況下。

區域洞察

在消費者意識不斷提高、人口老化以及強大的美容文化的推動下，美洲的臉部注射劑市場正在不斷發展。公司不斷創新並投資於研發，以獲得競爭優勢，更持久、更安全的填料的最新專利就證明了這一點。供應商也擴大客製化他們的產品和服務，以適應不同種族群體和個人的偏好。此外，由於消費者重視自然效果，供應商正在採用更精緻、更精確的技術和產品。由於監管限制、文化觀念和經濟狀況的差異，歐盟國家的臉部注射劑市場差異很大。偏好自然外觀和保守的整容方法是歐盟市場的普遍特徵。歐盟醫療設備法規 (MDR) 等監管改革正在重塑產業內的標準和實踐。中東地區的情況多種多樣，由於許多國家在整容手術上的人均支出很高，因此佔了很大的需求比例。非洲市場潛力巨大，一些國家正在經歷都市化和經濟開拓。這兩個地區的抗老化治療意識不斷增強，推動了臉部注射劑市場的發展。亞太地區臉部注射劑市場正在快速成長，想要改善外表的中年人和年輕人對整容手術的接受度迅速提高。市場也見證了本土投資利用中階不斷成長的購買力以及挑戰國際品牌的國內企業的崛起。此外，消費者更喜歡高品質、技術先進的產品，新注射劑的早期採用就證明了這一點。該國的法規也向市場通報美容醫學的安全性和準確性。

FPNV定位矩陣

FPNV定位矩陣對於評估臉部注射劑市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對臉部注射劑市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.臉部注射劑市場的市場規模和預測是多少？

2.在臉部注射劑市場預測期間內，有哪些產品、細分市場、應用和領域需要考慮投資？

3.臉部注射劑市場的技術趨勢和法規結構是什麼？

4.臉部注射劑市場主要供應商的市場佔有率是多少？

5.進入臉部注射劑市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人民可支配收入增加，整容需求增加
      • 世界各地的消費者越來越重視自己的外表
      • 人們對微創手術的興趣日益濃厚
    • 抑制因素
      • 整容手術的有限報銷政策
    • 機會
      • 引入新型填充劑和抗衰老肉毒桿菌注射療法並獲得監管部門核准
      • 化妝品旅遊的興起
    • 任務
      • 關於臉部注射產品和相關副作用的嚴重監管問題
  • 市場區隔分析
    • 類型：抗老化老注射因其恢復臉部體積的能力而變得越來越受歡迎
    • 最終使用者：皮膚科診所擴大採用臉部注射劑
  • 市場趨勢分析
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析
  • 客戶客製化

第6章臉部注射劑市場：按類型

  • 抗老化注射
  • 真皮填充劑

第7章臉部注射劑市場：依最終用戶分類

  • 美容診所
  • 皮膚科診所
  • 皮膚科研究所
  • 醫院

第8章 北美、南美臉部注射劑市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區臉部注射劑市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東、非洲臉部注射劑市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • DAXXIFY 成為第一個被《時代》雜誌評為最佳發明的臉部注射劑
    • JUVEDERM 的 SKINVIVE 獲得美國FDA核准
    • Symatese 與美國Evolus 合作推出新的 HA 真皮填充劑系列

第12章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-0355054AC48C

[188 Pages Report] The Facial Injectables Market size was estimated at USD 17.30 billion in 2023 and expected to reach USD 19.30 billion in 2024, at a CAGR 11.77% to reach USD 37.72 billion by 2030.

Facial injectables are medical treatments administered through injections to enhance facial aesthetics, rejuvenate skin, and treat various signs of aging. They are minimally invasive procedures that can temporarily improve skin tone, texture, and structure. The rising demand for minimally invasive aesthetic treatments, technological advancements in product development, and increased disposable income enable more individuals to afford such procedures. However, the high cost of procedures and the risk of complications and adverse effects post-injection is a significant concerns that can deter potential clients. Nevertheless, advancements in personalized medicine, such as customized injectables tailored to individual facial anatomy and desired outcomes, offer untapped potential coupled with ongoing research into the safety and efficacy of these treatments, which is expected to create lucrative opportunities for the facial injectables market.

KEY MARKET STATISTICS
Base Year [2023] USD 17.30 billion
Estimated Year [2024] USD 19.30 billion
Forecast Year [2030] USD 37.72 billion
CAGR (%) 11.77%

Type: Burgeoning preference for anti-aging injections due to its ability to restore facial volumes

Anti-aging injections encompass a range of products designed to decrease the signs of aging by smoothing wrinkles and restoring facial volume. They work by relaxing the facial muscles or filling in wrinkles and are administered by healthcare professionals. Botulinum Toxin A is a neuromodulator used to relax facial muscles temporarily. It is one of the most popular anti-aging treatments for lowering the appearance of dynamic wrinkles, particularly in the upper face, such as forehead lines, crow's feet, and frown lines. Poly-L-Lactic Acid (PLLA) is a biodegradable synthetic substance used as microparticles. As a stimulatory filler, PLLA is administered to the deeper layers of the skin to help stimulate the skin's production of collagen over time, gradually increasing skin thickness and smoothing wrinkles. Dermal fillers are injectable products utilized to add volume, change the contours of the face, and fill in wrinkles. Common areas for treatment comprise the lips, cheeks, nasolabial folds, and marionette lines. Fillers are composed of various substances, some naturally occurring and some synthetic. Collagen fillers are derived from either human or animal collagen and are used to supplement the body's natural collagen, which depletes with age. These fillers can improve the appearance of fine lines and wrinkles and provide a moderate lifting effect, but they tend to break down faster than other filler types. Hyaluronic acid is a naturally arising substance in the skin that retains moisture and creates a plump and hydrated look. Hyaluronic acid fillers are used for facial injections because of their compatibility with the body and can dissolve naturally over time. They are commonly used for lip augmentation, contouring, and treating medium to severe facial folds and wrinkles. Synthetic fillers comprise lab-made substances that do not naturally occur in the skin. These fillers, such as calcium hydroxylapatite, polylactic acid, and polymethylmethacrylate beads, provide longer-lasting results than those with substances that are absorbed by the body and are used for deep wrinkles, volume loss, and facial contouring.

End User: Evolving adoption of facial injectables by dermatology clinics

Beauty clinics represent a significant segment of facial injectables, given their specialization in cosmetic procedures. These establishments commonly provide a variety of non-surgical aesthetic treatments, including Botox, dermal fillers, and other injectables aimed at enhancing facial features and reducing signs of aging. Dermatology clinics are a critical end-user of facial injectables. These medical facilities are operated by board-certified dermatologists who administer injectables as part of a broader range of skin health services. Facial injectables in these settings are used for aesthetic enhancement and therapeutic purposes, such as treating medical conditions, including hyperhidrosis or certain types of migraines. Dermatology Research Institutes are pivotal in advancing facial injectable products and techniques. These institutions prioritize facial injectables that have the potential for innovation and breakthroughs in dermatological science. They may work directly with manufacturers in clinical trials or studies to evaluate long-term efficacy and safety. Preference is given to products that allow researchers to explore new populations, indications, or delivery methods. Hospitals' use of facial injectables revolves around reconstructive or therapeutic treatments rather than cosmetic enhancements. Patients may receive facial injectables for rehabilitation after traumatic injuries or surgeries or for the treatment of medical conditions such as migraines or excessive sweating. Hospitals prefer versatile products, have a strong safety record, and are cost-effective, especially when dealing with medical insurance and budget constraints.

Regional Insights

The facial injectables market is evolving in the Americas, driven by heightened consumer awareness, a growing aging population, and a strong culture of cosmetic enhancement. There is a significant investment in R&D, with companies constantly innovating to gain a competitive edge, as seen in the latest patents for longer-lasting and safer fillers. Providers are also increasingly tailoring their products and services to cater to diverse ethnic groups and individual preferences. Furthermore, consumers value natural-looking results, prompting providers to adopt techniques and products that deliver subtlety and precision. The facial injectables market across EU countries varies widely due to differing regulatory restrictions, cultural perceptions, and economic status. A preference for natural appearance and conservative approaches to cosmetic procedures generally distinguishes the EU market. Regulatory innovations such as the EU's Medical Device Regulation (MDR) are reshaping standards and practices within the industry. The MEA region presents a diverse landscape, with the Middle East accounting for a substantial share of demand due to the high per capita expenditure on cosmetic procedures in many countries. The African market shows potential with rising urbanization and economic development in certain countries. Both regions exhibit an increased awareness of anti-aging treatments, driving the market for facial injectables. The Asia-Pacific facial injectables market is burgeoning, with a sharp growth in the acceptance of aesthetic procedures among middle-aged and younger cohorts looking to enhance their appearances. The market is also witnessing local investments and the emergence of domestic players challenging international brands, capitalizing on the growing middle class's purchasing power. Furthermore, consumers prefer high-quality and technologically advanced products, demonstrated by their quick adoption of novel injectables. The country's regulatory emphasis also informs the market on safety and precision in aesthetic medicine.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Facial Injectables Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Facial Injectables Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Facial Injectables Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Advanced Dermatology and Cosmetic Surgery, ALPHAEON Corporation, Anika Therapeutics, Inc, Antares Pharma, Inc. by Halozyme Therapeutics, Inc., Bausch Health Companies Inc., Becton, Dickinson and Company, Bloomage BioTechnology Corporation Limited, Eisai Co., Ltd., Fidia Farmaceutici S.p.A., Galderma Laboratories, L.P., Galderma S.A., Inovio Pharmaceuticals Inc., Ipsen Pharma, Johnson & Johnson Services, Inc., Mastelli Srl, Medytox Inc., Merz Pharma GmbH & Co KGaA, Novartis AG, Pfizer Inc., Prollenium Medical Technologies Inc., Remedium Korea, Sanofi S.A., Sinclair Pharma Group, Suneva Medical, Inc., and Zimmer Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Facial Injectables Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Anti-aging Injections
      • Botulinum Toxin A
      • Poly-L-Lactic Acid (PLLA) Micro Particles
    • Dermal Fillers
      • Collagen Fillers
      • Hyaluronic Acid
      • Synthetic Fillers
  • End User
    • Beauty Clinics
    • Dermatology Clinics
    • Dermatology Research Institutes
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Facial Injectables Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Facial Injectables Market?

3. What are the technology trends and regulatory frameworks in the Facial Injectables Market?

4. What is the market share of the leading vendors in the Facial Injectables Market?

5. Which modes and strategic moves are suitable for entering the Facial Injectables Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing Disposable Income Among People and Increased Demand for Cosmetic Procedures
      • 5.1.1.2. Increasing Focus on Physical Appearance Among Consumers Globally
      • 5.1.1.3. Rising Inclination Toward Minimally Invasive Procedures Among People
    • 5.1.2. Restraints
      • 5.1.2.1. Limited Reimbursement Policies Supporting Cosmetic Procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of New Fillers and Anti-Aging Botulinum Toxin Injection Therapies coupled with Regulatory Approvals
      • 5.1.3.2. Rise in the Cosmetic Tourism
    • 5.1.4. Challenges
      • 5.1.4.1. Strict Regulatory Concerns about Facial Injectable Products and Relative Side Effects
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Burgeoning preference for anti-aging injections due to its ability to restore facial volumes
    • 5.2.2. End User: Evolving adoption of facial injectables by dermatology clinics
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Facial Injectables Market, by Type

  • 6.1. Introduction
  • 6.2. Anti-aging Injections
  • 6.3. Dermal Fillers

7. Facial Injectables Market, by End User

  • 7.1. Introduction
  • 7.2. Beauty Clinics
  • 7.3. Dermatology Clinics
  • 7.4. Dermatology Research Institutes
  • 7.5. Hospitals

8. Americas Facial Injectables Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Facial Injectables Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Facial Injectables Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. DAXXIFY Becomes First Facial Injectable to be Named to TIME's Best Inventions
    • 11.3.2. SKINVIVE by JUVEDERM Receives U.S. FDA Approval
    • 11.3.3. Symatese Announces Its Partnership With Evolus In The USA Regarding Its New Range Of HA Dermal Fillers

12. Competitive Portfolio

  • 12.1. Key Company Profiles
  • 12.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. FACIAL INJECTABLES MARKET RESEARCH PROCESS
  • FIGURE 2. FACIAL INJECTABLES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FACIAL INJECTABLES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. FACIAL INJECTABLES MARKET DYNAMICS
  • FIGURE 7. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. FACIAL INJECTABLES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 20. FACIAL INJECTABLES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FACIAL INJECTABLES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FACIAL INJECTABLES MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL FACIAL INJECTABLES MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN A, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN A, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY POLY-L-LACTIC ACID (PLLA) MICRO PARTICLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY POLY-L-LACTIC ACID (PLLA) MICRO PARTICLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY COLLAGEN FILLERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY COLLAGEN FILLERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY SYNTHETIC FILLERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY SYNTHETIC FILLERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY BEAUTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY BEAUTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 51. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 52. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 59. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 60. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 61. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 62. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 63. CANADA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. CANADA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. CANADA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 66. CANADA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 67. CANADA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 68. CANADA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 69. CANADA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 70. CANADA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 71. MEXICO FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 72. MEXICO FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 73. MEXICO FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 74. MEXICO FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 75. MEXICO FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 76. MEXICO FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 77. MEXICO FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 78. MEXICO FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 79. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 82. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 83. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 84. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 85. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 86. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 87. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 88. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 102. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 104. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 106. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 107. CHINA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. CHINA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. CHINA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 110. CHINA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 111. CHINA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 112. CHINA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 113. CHINA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 114. CHINA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 115. INDIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. INDIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. INDIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 118. INDIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 119. INDIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 120. INDIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 121. INDIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 122. INDIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 123. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 126. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 127. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 128. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 129. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 130. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 131. JAPAN FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. JAPAN FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. JAPAN FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 134. JAPAN FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 135. JAPAN FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 136. JAPAN FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 137. JAPAN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 138. JAPAN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 139. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 142. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 143. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 144. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 145. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 146. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 150. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 152. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 154. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 155. SINGAPORE FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. SINGAPORE FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. SINGAPORE FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 158. SINGAPORE FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 159. SINGAPORE FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 160. SINGAPORE FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 161. SINGAPORE FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 162. SINGAPORE FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 166. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 168. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 170. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 171. TAIWAN FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. TAIWAN FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. TAIWAN FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 174. TAIWAN FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 175. TAIWAN FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 176. TAIWAN FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 177. TAIWAN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 178. TAIWAN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 179. THAILAND FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. THAILAND FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. THAILAND FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 182. THAILAND FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 183. THAILAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 184. THAILAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 185. THAILAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 186. THAILAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 187. VIETNAM FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. VIETNAM FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. VIETNAM FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 190. VIETNAM FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 191. VIETNAM FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 192. VIETNAM FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 193. VIETNAM FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 194. VIETNAM FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 205. DENMARK FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 206. DENMARK FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 207. DENMARK FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 208. DENMARK FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 209. DENMARK FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 210. DENMARK FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 211. DENMARK FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 212. DENMARK FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 213. EGYPT FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. EGYPT FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. EGYPT FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 216. EGYPT FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 217. EGYPT FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 218. EGYPT FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 219. EGYPT FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 220. EGYPT FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 221. FINLAND FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. FINLAND FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. FINLAND FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 224. FINLAND FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 225. FINLAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 226. FINLAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 227. FINLAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 228. FINLAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 229. FRANCE FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 230. FRANCE FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 231. FRANCE FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 232. FRANCE FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 233. FRANCE FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 234. FRANCE FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 235. FRANCE FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 236. FRANCE FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 237. GERMANY FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. GERMANY FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. GERMANY FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 240. GERMANY FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 241. GERMANY FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 242. GERMANY FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 243. GERMANY FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 244. GERMANY FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 245. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 246. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 247. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 248. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 249. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 250. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 251. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 252. ISRAEL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 253. ITALY FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. ITALY FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. ITALY FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 256. ITALY FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 257. ITALY FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 258. ITALY FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 259. ITALY FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 260. ITALY FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 264. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 266. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 268. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 269. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 272. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 273. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 274. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 275. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 276. NIGERIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 277. NORWAY FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 278. NORWAY FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 279. NORWAY FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 280. NORWAY FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 281. NORWAY FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 282. NORWAY FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 283. NORWAY FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 284. NORWAY FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 285. POLAND FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. POLAND FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. POLAND FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 288. POLAND FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 289. POLAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 290. POLAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 291. POLAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 292. POLAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 293. QATAR FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 294. QATAR FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 295. QATAR FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 296. QATAR FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 297. QATAR FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 298. QATAR FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 299. QATAR FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 300. QATAR FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 301. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 302. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 303. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 304. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 305. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 306. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 307. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 308. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 310. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 312. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 314. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 316. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 318. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 320. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 322. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 324. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 325. SPAIN FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 326. SPAIN FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 327. SPAIN FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 328. SPAIN FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 329. SPAIN FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 330. SPAIN FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 331. SPAIN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 332. SPAIN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 333. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 334. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 335. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 336. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 337. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 338. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 339. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 340. SWEDEN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 341. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 342. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 344. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2024-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2023 (USD MILLION)
  • TABLE 346. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2024-2030 (USD MILLION)
  • TABLE 347. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 348. SWITZERLAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 349. TURKEY FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 350. TURKEY FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 351. TURKEY FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2023 (USD MILLION)
  • TABLE 352. TURKEY FACIAL IN